These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33991474)

  • 1. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Logunov DY; Dolzhikova IV; Shcheblyakov DV
    Lancet; 2021 May; 397(10288):1883-1884. PubMed ID: 33991474
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
    Jarynowski A; Semenov A; Kamiński M; Belik V
    J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can children of the Sputnik V vaccine recipients become symptomatic?
    Mehraeen E; SeyedAlinaghi S; Karimi A
    Hum Vaccin Immunother; 2021 Oct; 17(10):3500-3501. PubMed ID: 34241575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The arrival of Sputnik V.
    Balakrishnan VS
    Lancet Infect Dis; 2020 Oct; 20(10):1128. PubMed ID: 32979327
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Logunov DY; Dolzhikova IV; Tukhvatullin AI; Shcheblyakov DV
    Lancet; 2020 Oct; 396(10256):e54-e55. PubMed ID: 32971043
    [No Abstract]   [Full Text] [Related]  

  • 6. Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Jones I; Roy P
    Lancet; 2021 Feb; 397(10275):642-643. PubMed ID: 33545098
    [No Abstract]   [Full Text] [Related]  

  • 7. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial.
    Bucci EM; Berkhof J; Gillibert A; Gopalakrishna G; Calogero RA; Bouter LM; Andreev K; Naudet F; Vlassov V
    Lancet; 2021 May; 397(10288):1881-1883. PubMed ID: 33991475
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
    Kasi SG; Shah A
    Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967
    [No Abstract]   [Full Text] [Related]  

  • 9. ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2021 Jun; 397(10291):2248. PubMed ID: 34119059
    [No Abstract]   [Full Text] [Related]  

  • 10. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 11. The promise of COVID-19 vaccines. Authors' reply.
    Sokolska JM; Kurcz J; Kosmala W
    Kardiol Pol; 2022; 80(1):111-112. PubMed ID: 34981827
    [No Abstract]   [Full Text] [Related]  

  • 12. Countries split from EU on COVID-19 vaccines.
    Holt E
    Lancet; 2021 Mar; 397(10278):958. PubMed ID: 33714379
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
    Alexander JL; Kennedy NA; Lees CW; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):523-524. PubMed ID: 34119033
    [No Abstract]   [Full Text] [Related]  

  • 15. Russian SARS-CoV-2 vaccine.
    Caddy S
    BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
    [No Abstract]   [Full Text] [Related]  

  • 16. The Covid-19 Vaccine-Development Multiverse. Reply.
    Heaton PM
    N Engl J Med; 2021 Feb; 384(7):682. PubMed ID: 33503339
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccines: early success and remaining challenges.
    Bar-Zeev N; Inglesby T
    Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290
    [No Abstract]   [Full Text] [Related]  

  • 18. The Russian vaccine for COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Nov; 8(11):e85-e86. PubMed ID: 32896274
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

  • 20. Current advances in the development of SARS-CoV-2 vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.